Zhang Haidong and his delegation from Shandong First Medical University (Shandong Academy of Medical Sciences) visited and conducted research at Yinfeng Biotechnology Group
On March 29th, Zhang Haidong, Executive Vice President of the School of Clinical and Basic Medicine at Shandong First Medical University (Shandong Academy of Medical Sciences), Yue Yun, Deputy Secretary of the Party Committee, and Wang Dandan, Vice President, visited and conducted research at Yinfeng Biotechnology Group. Zhang Cheng, President of Yinfeng Biotechnology Group, Zhang Guirong, Assistant to the President and Director of Research and Development Department, and Hu Jinkun, Director of Human Resources Department, accompanied the delegation.
Zhang Haidong and his delegation visited the "Infinite Life Plan" science popularization museum and the "Life Continuation Plan" exhibition hall, gaining a detailed understanding of cell storage and application scenarios in 5G scenarios, the first human low-temperature preservation case in Asia, and the infinite possibilities of deep cryogenic medicine in tissue and organ transplantation and clinical applications.
After the visit, Zhang Cheng, President of Yinfeng Biotechnology Group, and Zhang Haidong gave a comprehensive introduction to Yinfeng Biotechnology Group's industrial layout, cutting-edge technology, research and development innovation, and achievement transformation in the biomedical field. The two sides had in-depth exchanges on the joint construction of talent training bases and scientific research achievement transformation cooperation between the hospital and enterprises. They jointly signed a practical teaching base agreement and held a licensing ceremony.
Yinfeng Biotechnology Group is a high-tech enterprise driven by "cell+gene" dual engine innovation, specializing in the research and development, medical transformation, and clinical research of biomedical technologies such as human cell, tissue, and organ storage, gene sequencing, cell application, deep and low-temperature medicine, and health management services. With 20 years of deep cultivation, Yinfeng Biotechnology has taken the lead in connecting the entire human life cycle health management service industry chain nationwide To become a leading domestic and internationally first-class human lifecycle health management service provider and contribute Yinfeng's strength to the development vision and serving "Healthy China".
On August 23, the Jinan Private Economic Development Bureau and China Economic Weekly jointly launched the theme publicity activity of "Central Media Look at Jinan - Entering Jinan's Private Economy" in Yinfeng Biotechnology Park.
Led by Anhui Medical University and participated by Yinfeng Cryogenic Medical Technology Co., Ltd., the "Engineering Research Center for Life Resources Conservation and Artificial Organs of the Ministry of Education" was officially accepted and awarded by the Ministry of Education. As one of the four major platforms for the transformation of the center's project, Yinfeng Cryogenic Co., Ltd. is responsible for the "development, promotion and application of cryogenic preservation technology of biological matrix materials".
On March 28, 2023, the kick-off meeting of the International Alliance for Life Extension Research was held in Jinan, Shandong. The "International Alliance for Life Extension Research" was initiated by Shandong Yinfeng Life Science Research Institute, and jointly established by 13 international scientific research institutions engaged in the field of cryogenic biomedicine from North America, Europe, Oceania, etc., and appeared at the conference through online and offline forms.